Evidence map›Paper›PMID 29920278›Full record

ArticleDevelopmental cell2018

Competition between TIAM1 and Membranes Balances Endophilin A3 Activity in Cancer Metastasis.

Kumud R Poudel, Minna Roh-Johnson, Allen Su, Thuong Ho, Haritha Mathsyaraja, Sarah Anderson, William M Grady, Cecilia B Moens, Maralice Conacci-Sorrell, Robert N Eisenman and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Developmental cell, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. GEFT aberrant expression in soft tissue sarcomas.Translational cancer research · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Kumud R PoudelBasic Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA.
Minna Roh-JohnsonBasic Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA.
Allen SuBasic Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA.
Thuong HoBasic Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA.
Haritha MathsyarajaBasic Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA.
Sarah AndersonBasic Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA.
William M GradyClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Cecilia B MoensBasic Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA.
Maralice Conacci-SorrellSimmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Robert N EisenmanBasic Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA. Electronic address: eisenman@fredhutch.org.
Jihong BaiBasic Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA. Electronic address: jbai@fredhutch.org.
North Seattle College · USCape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZAFred Hutch Cancer Center · USThe University of Texas Southwestern Medical Center · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
Interdisciplinary Tranining in Cancer ResearchT32CA080416 · NCI · UNIVERSITY OF WASHINGTON · PI STODDARD, BARRY L. · 1998 to 2023
$9.7M
The MYC Transcription Factor Network and the Path to CancerR35CA231989 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI EISENMAN, ROBERT NEIL · 2018 to 2024
$6.3M
MYC ONCOPROTEIN FUNCTIONR01CA057138 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI EISENMAN, ROBERT NEIL · 1991 to 2018
$4.9M
Membrane Bending Machinery for Synaptic Vesicle EndocytosisR01NS085214 · NINDS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BAI, JIHONG · 2013 to 2017
$1.9M
Cell Biological Mechanisms of Melanoma Cell Motility In VivoR00CA190836 · NCI · UNIVERSITY OF UTAH · PI ROH, MINNA · 2018 to 2020
$954k
Cell Biological Mechanisms of Melanoma Cell Motility in vivoK99CA190836 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ROH, MINNA · 2015 to 2016
$229k
NCI NIH HHS K99 CA190836NCI NIH HHS P30 CA015704NCI NIH HHS R00 CA190836NCI NIH HHS R01 CA057138NCI NIH HHS R35 CA231989NCI NIH HHS T32 CA080416NINDS NIH HHS R01 NS085214
6 · The paper itself

Abstract

Normal cells acquire aggressive behavior by modifying signaling pathways. For instance, alteration of endocytosis profoundly impacts both proliferation and migration during tumorigenesis. Here we investigate the mechanisms that enable the endocytic machinery to coordinate these processes. We show that a membrane curvature-sensing protein, endophilin A3, promotes growth and migration of colon cancer cells through two competing mechanisms: an endocytosis pathway that is required for proliferation and a GTPase regulatory pathway that controls cell motility. EndoA3 stimulates cell migration by binding the Rac GEF TIAM1 leading to activation of small GTPases. Competing interactions of EndoA3 with membrane versus TIAM1 modulate hyperproliferative and metastatic phenotypes. Disruption of EndoA3-membrane interactions stimulates TIAM1 and small GTPases in vitro, and further promotes pro-metastatic phenotypes in vivo. Together, these results uncover a coupling mechanism, by which EndoA3 promotes growth and migration of colon cancers, by linking membrane dynamics to GTPase regulation.

Indexed as

AcyltransferasesAnimalsCarcinogenesisCell Line, TumorCell MovementCell ProliferationCell Transformation, NeoplasticColonic NeoplasmsEndocytosisGTP PhosphohydrolasesGuanine Nucleotide Exchange FactorsHumansMiceNeoplasm Metastasisrac1 GTP-Binding ProteinSignal Transduction2-acylglycerophosphate acyltransferaseAcyltransferasesGTP PhosphohydrolasesGuanine Nucleotide Exchange Factorsrac1 GTP-Binding ProteinTIAM1 protein, humanT-Lymphoma Invasion and Metastasis-inducing Protein 1BAR domaincell migrationendocytosisendophilinmembrane remodelingmetastasisPTENRac1TIAM1

Identifiers

PMID29920278
PMCPMC6095642
OpenAlexW2808634110

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.